Cognidox rolls out new training analytics and project cloning features in v10.2




Cambridge, UK, 3 May 2022: Cognidox, a leading provider of document management solutions for the high-tech, medical device, and life sciences industries, has unveiled the latest innovations in their v10.2 platform release.

The Q2 rollout of Cognidox 10.2 includes a new training analytics dashboard, project master cloning capabilities, improvements to shared notes, a new search engine, new login screens and more flexible two-factor authentication (2FA) options.

Joe Byrne, CEO of Cognidox, describes the two major enhancements driving the release:

Training analytics

“Cognidox’s new training analytics dashboard gives companies a comprehensive overview of workers’ acknowledgement of critical policies and procedures. Users can now track training attestation in a simple matrix view, helping meet some of the critical reporting requirements of ISO 13485:2016 and other quality standards.”

 Cognidox v10.2 launch

Project cloning

With Cognidox v10.2 setting up new projects and multiple LAP partner areas has never been easier:

“Developers and consultants can now clone existing project structures at the touch of a button. Every document within an existing structure can be replicated instantly and renamed to support a brand new client or NPI process.”

There are also upgrades for shared notes capabilities, including a new rendering engine, mouse controls and editing features. Meanwhile, the release enables 2 Factor Authentication with a new MySQL Password plugin.

Cognidox continues to improve clients’ document control capabilities with their new and powerful features, making their platform ever faster and more intuitive.

About Cognidox

Cognidox is a leading document management software provider for the high-tech, medical device, and life science product sectors. The Cognidox DMS improves visibility and control for the development process and an entire business.

Founded in 2008 by Vittal Aithal and Paul Walsh, the Cambridge based company started life as “Doxbox” – an in-house tool for the fabless semiconductor company Virata. The goal was to make product development better by breaking down barriers between teams and making peer reviews much easier. 

Today, it is powering the development of cutting-edge products in the semiconductor, medical device and IVD device industries. Its lean DMS supports customers in creating more efficient, sustainable and compliant product development processes. It helps companies build robust Quality Management Systems that can flex with their needs.

Cognidox is validated for use with ISO 13485, ISO 9001, FDA 21 CFR 820, FDA 21 CFR 11, ISO 26262 and GxP.

To find out more about Cognidox, visit the website:


For more information:

Joe Byrne


+44 (0)1223 911080

Cognidox Medical Device FDA

Tags: Company News

Joe Byrne

Written by Joe Byrne

Joe Byrne is the CEO of Cognidox. With a career spanning medical device start-ups and fortune 500 companies, Joe has over 25 years of experience in the medical device and high-tech product development industries. With extensive experience in scaling businesses, process improvement, quality, medical devices and product development, Joe is a regular contributor to the Cognidox DMS Insights blog where he shares expertise on scaling and streamlining the entire product development cycle, empowering enterprises to achieve governance, compliance, and rigour.

Related Posts

Announcing CogniCon 24 - save the date!

The Cognidox team is delighted to announce we will be hosting CogniCon 24 on 16 May 2024. This is a ...

Cognidox announces new e-signature integration with DocuSign

Cognidox are delighted to announce the release of our new DocuSign e-signature integration. The new ...